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1. Introduction 
Trauma is the most common cause of death in developed countries among the population 
under 40 and the fourth overall cause of death in the general population. In the USA 4.6% of all 
deaths per year are due to accidental injuries.  The hospital expenses for injured patients are 
higher compared to the expenses for patients hospitalized due to other causes.1 Injury-induced 
anergy is one of the key factors contributing to trauma victims’ high susceptibility to sepsis. 
Patients are mostly young and it is therefore essential to be able to predict as accurately as 
possible the development of septic complications so that the appropriate treatment could be 
provided. Multiple organ failure (MOF) is the leading cause of late death following trauma.[2] 
The term defines an “all-or-nothing” event and represents only the extreme points of a 
continuous dynamic process of organ function deterioration. Nowadays the concept of MOF 
could be revisited as a transient state of metabolic shutdown analogous to hibernation. 
Avoiding the detrimental effects of inappropriate and counter-adaptive iatrogenic interventions 
is an important cornerstone of therapeutic management.[3]  Severity of injury, late or inadequate 
resuscitation, inadequate surgical intervention, persistent inflammatory focus, previous organ 
damage, chronic disease and age over 65 may affect the presentation and the outcome of MOF. 
Studies demonstrate that the degree of an initial injury is important in determining the patient’s 
susceptibility to post-traumatic complications, but the issue of secondary surgical procedures 
acting as additional inflammatory insults (second hit) and a genetic predisposition are 
suspected to be responsible for different outcomes.[4] These factors can explain why some 
patients develop serious post-traumatic complications and others do not, despite the same 
injury severity scores. It is still not possible to identify the risk group when efficient intervention 
could be undertaken. There is a tight correlation between the cytokin plasma level, the 
development of MOF and the mortality rate.[5] Immunological system plays a major role in an 
inflammatory response to trauma, which leads to the negative outcome without a  direct 
connection to the severity of trauma or quality of the initial treatment. 
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The development of immunomonitoring would help in the selection of patients at risk of 
post-traumatic complications and, thereby, the choice of the most appropriate treatment 
protocols for severely injured patients.[6]  
Trauma triggers a complex cascade of post-traumatic events that are important when 
predicting the outcome in the first few days after the trauma.[7] Mediators play an important 
role in the development of the systemic inflammatory response syndrome (SIRS), multiple 
organ dysfunction (MODS) and multiple organ failure (MOF), the last two associated with 
high mortality.  In critically injured patients who underwent resuscitation early, non-
infective SIRS  develops.  A severe trauma can provoke  serious SIRS, although mild SIRS 
can be useful and helpful in patient recovery.  The objectives of the therapy should be 
pointed towards modulating early SIRS. [8,9] 
Interleukin 6 (IL-6) plasma level could be the marker of cytokine's cascade activity and 
might show the severity of  injury. In patients with an obscure sepsis syndrome, IL-6 plasma 
levels are well correlated to the later sepsis development and consecutive mortality.[10,11,12] 
The experiments in vitro showed that human monocytes produce interleukin 10 (IL-10) after 
lipopolysacharide stimulation, later compared to the production of the tumor necrosis factor 
(TNF)-, IL-1, IL-6, or IL-8. The presence of anti IL-10 blocking antibodies in the cell culture 
results in production increase of these cytokines, implicating on the regulatory function of 
IL-10. IL-10 plasma levels are significantly increased in critically injured patients, especially 
in patients with sepsis, suggesting that this cytokine is an important inflammation 
mediator.[13,14] 
Infection is identified as the essence of the major cause of multiple organ dysfunction in 
critically injured patients. [15,16] The course of patophysiological events, especially in the early 
post-traumatic period, is very important in predicting the outcome.[17,18] 
The objectives of the study were to: 
1. determine blood levels of C reactive protein (CRP), immunoreactive phospholypase A2 
group II (PLA2-II), IL-6 and IL-10 concentration as quantifiable parameters of the 
outcome for critically injured patients; 
2. evaluate prognostic values of the Simplified Acute Physiology Score (SAPS II), Injury 
Severity Score (ISS) score values and multiple organ failure (MOF) signs;  
3. construct early predictive models for the outcome prediction. 
2. Material and methods 
A prospective 65- subject- study was performed  at the Intesive Care Unit (ICU) of the 
Clinical Center of Serbia. The atients met the following criteria: ISS  18, aged 16-65 , 
admittance in the first 24 hours after the trauma, survival longer than 48  hours. Patients 
with the leading neurosurgical trauma were excluded.  
Mediators of inflammation were determined in all patients within the first 24 hours, on the 
second, third, seventh and tenth day of hospitalization. CRP concentration was determined 
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by immunonephelometry on «Behring» laser nephelometer (normal value <9 mg/mL). 
Phospholipase A2-II concentration was determined with enzyme-linked immunoadsorbent 
assay (ELISA), Boehringer Mannheim GmbH, Germany. Interleukin concentration was 
determined with Immunotech test based on «sandwich» enzyme immunodetermination. 
The reference range for IL-6 was 0 - 8 pg/mL and for IL-10 0 - 10 pg/mL. 
We applied the MOF  score, in which the presence of organic damages is defined by the 
presence of one or more characteristics.[19,20]  Lung dysfunction is defined as mandatory 
mechanical ventilation, for at least 72 hours, PO2/FiO2 < 37,3 kPa, positive end expiratory 
pressure greater than 8 cm H2O, ARDS verified using X-ray, or respiratory frequence  
5/min or  49/min. Liver insufficiency is defined as bilirubinaemya >51 mol/L, at least for 
48 hours; heart insufficiency is defined as cardiac index <3,0  L x min-1 x m-2, mandatory use 
of inotropic drugs, heart frequency  54/min, the presence of ventricular tachycardia and/or 
fibrilation, mean arterial pressure  49 mm Hg or pH  7,24; renal insufficiency is defined as 
blood level of serum creatinine >177 mol/ L; haemathologic insufficiency is 
thrombocytopenia (<20000 cells/mm3) or leucocytopenia (<1000 cells/ mm3). All these 
analyses were conducted daily. The worst value was taken into account when defining the 
presence of organic  insufficiency (the presence of only one of these listed meant the 
presence of insufficiency). 
The criteria for defining the presence of the SIRS were: body temperature >38 or <36 C, 
heart frequency greater than 90 bpm, tachypnea (>20 respiration per minute at room 
temperature or PaCO2 <4.3 Kpa), WBC >12000 cells/mm3 or < 4000 cells/mm3, or presence of 
more than 10% immature neutrofils (bands). [21] 
Simplified Acute Physiology Score (SAPS II) is made out of 17 variables: 12 of them are 
physiological, age, type of treatment (urgent surgery, planned surgery or non-operative 
treatment) and three variables are connected to the existence  of chronic commorbidities, 
such as AIDS, metastatic cancer or hematologic malignancy. Each  of these variables   was 
given a certain number of points ranging from 0 to 3 (for body temperature) or from 0 to 26 
(for the Glasgow Comma Scale). For 12 physiologic variables we took the worst values (with 
the highest number of points) during the first 24 hours after admission in ICU.[22] 
ISS  was calculated in a standard manner, by squaring the highest individual values for 
three body regions in the first 24 hours: ISS = AIS2 +AIS2 + AIS2. [23,24] 
The Chi2 test   was used for estimating the difference of frequency for categories that 
behaved according to the nominal scale. The  differences between numerical charactistics 
were tested using the t-test.  The Mann Whitney U test or Wilcoxon's test of pairs were used 
if the distribution was significantly different from normal. Each variable was assessed 
individually with the univariate analysis as a resulting variable for survival. The parameters 
that were found to be statistically significant predictors with the univariate analysis were 
included in the multivariate model. The logistic regression coefficient was used to  analyse 
the correlation between the daily average CRP, IL-6, IL-10 and PLA2-II concentrations and 
mortality. Values p<0.05 or p<0,01 were considered significant. 
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3. The results 
Sixty five patients (52 male and 13 female), average age 47.13 ± 15.03 years, were included  
in this study. This can be explained by a  greater exposure of men to trauma. There is a 
signifficant age difference among groups with MOF and without MOF (t= - 2.058, p=0.044) 
and survived and deceased patients group (t = - 3.26; p= 0.002). The most frequent was blunt 
trauma (51 patient, 78.1%), 14 patients (21.9%) had open wounds. Fourty three (66.1%) 
patients underwent surgical intervention, while 22 (33.9%) patients were treated non-
operatively. The overall hospital stay was 23.85 ± 5.94 days, ranging from two days (which is 
a minimal entry criterion for this study) to 131 days. The overall mortality rate was 50.76% 
(33 died, 32 survived).  After a severe trauma MOF developed in 36 patients, while 29 were 
with no MOF signs. The mortality rate in the group of patients with MOF was 75%. 
Concerning the outcome, there is a  significant difference  between  the groups with and 
without MOF (Pearson –20,571 (b), p=,000). 
The average CRP daily values, in both survived and deceased patients, are shown in the 
Table 1. There was a significant difference, with the highest value for the seventh day of 
hospitalization (Mann – Whitney U test). The level of correlation of serum concentrations 
and the survival rate is very high for the third and seventh day of hospitalization, and it is 
significant for the first (R1), second (R2) and tenth day (R10) of hospital stay (R3 = 0,4355, R7 = 
0,5460, R1= 0,3246, R2 = 0,3610, R 10 = 0,3517). The average IL-6 values for each day of the two 
observed groups are shown in  Table 1. There is a highly significant difference in IL-6 
average values between the two observed groups for the four initial days of hospitalization, 
especially in the first three days. There is also a significant correlation between serum 
concentration and the overall survival, especially in two starting days (R1 = 0,4278, R2 = 
0,4338), but with remaining significance for the third and seventh day, (R3 = 0,4018, R7 = 
0,3082 ). There is a highly significant difference for the IL-10 concentration for the first three 
days and also for the tenth day of hospitalization. But, there is a high degree of correlation 
for the serum concentration of this cytokine and the negative outcome for the second day of 
hospitalization (R2 = 0,2491). 
We also compared average PLA2  group II serum concentrations in the two observed groups, 
in the same manner and  at the same time as described previously. 
There is a substantial difference in average PLA2 II levels in the first four measurments 
related to the outcome. There is a strong correlation  between  its values and the outcome, 
especially for the measurments conducted on the first, second, third and seventh day (R1 = 
0,3188, R2 = 0,2766, R3 = 0,2911, R7 = 0,2977). 
There is a signifficant difference in the number of positive SIRS characteristics for the day 1, 
4. and 5 between the observed groups. There is also a huge statistically significant 
correlation  between the SIRS charactersistics and the survival rate for the first, second, 
fourth and fifth day of hospitalization (Table 2). 
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Days CRP IL-10 IL-6 PLA2 
1. 
S 129,83±13,44** 144,90±46,30** 256,59±75,34** 42,69±8,61 
D 212,83±18,29 285,96±64,28 804,33±96,62 120,68±19,94 
2. 
S 148,66±14,40** 64,95±14,31** 189,69±57,71** 57,42±11,90 
D 256,03±22,00 244,20±64,02 655,41±86,82 126,25±18,39 
3. 
S 141,99±14,59** 47,31±13,56** 106,81±26,87** 51,48±9,49 
D 257,28±18,27 161,50±53,28 437,18±79,55 119,80±19,62 
7. 
S 127,57±13,41** 34,75±14,93** 72,75±19,96** 41,75±9,00 
D 274,20±18,53 153,50±53,57 373,14±109,0 125,87±27,88 
10. 
S 163,71±25,69** 32,14±15,09 96,57±44,42 78,79±21,28 
D 275,38±26,33 86,83±45,69 151,66±44,76 109,48±32,45 
C-reactive protein - CRP in mg/l  
interleukin (IL) 6 (pg/mL)  
IL-10 (pg/mL)  
phospholipase A2 (PLA2 in ng/L)  
survived (S) ,deceased (D)  
*  p<0,05 
**p<0,01 
Table 1. Average C-reactive protein, interleukin 6, interleukin 10 and phospholipase A2 in survived (S) 
and deceased (D) patients following severe trauma (Mann Whitney U test). 
 
days SIRS1 SIRS2 SIRS3 SIRS4 SIRS5 SIRS6 SIRS7 
S 2,31±0,06 2,31±0,09 2,13±0,12 2,04±0,10 1,85±0,15 2,25±0,13 2,30±0,15 
D  2,71±0,03 2,56±0,08 2,54±0,10 2,62±0,13 2,87±0,12 2,70±0,16 2,76±0,18 
p <0,01 >0,05 >0,05 <0,01 <0,01 >0,05 >0,05 
pR <0,01 <0,01 <0,05 <0,01 <0,01 >0,05 >0,05 
p – derived from t-test 
pR – derived from logistic regression coefficient 
Table 2. Number of positive systemic inflammatory response (SIRS) variables per hospital days in 
survived (S) and deceased (D)patients 
SAPS II values in both groups are higly different ( t = - 5.805; p<0.000), Table 3. The degree of 
correlation shows a considerable significance for the method of logistic regression (R = 
0.4811; p<0.000). The prognostic power of this score considering the outcome is 78.13% in 
our series. 
The anatomic score model for injury severity, ISS, in the group of survivors (27,62  5,31 
SD) and the group of deceased are highly different (t= - 4.103; p<0.0001), Table 3. Its  
predictive power in our series was 75%. The method of logistic regression shows a highly 
significant correlation between the severity of the injury (ISS) and the survival rate (R = 
0.3627).  
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 ISS SAPS2 
S 27,62±5,09 (SD) 31,39±9,24 (SD) 
D 33,34±6,01 (SD) 47,31±11,8 (SD) 
R 0,3627 0.4811 
p <0,01 <0,01 
R- logistic regression coefficient 
p - derived from t-test 
Table 3. The Injury Severity Score (ISS) and Simplified Acute Physiology Score (SAPS II) values in 
survived (S) and deceased (D) patients  
The mutual effect of all significant variables obtained by the univariate analysis is examined 
by the multivariate logistic regression model, estimating that the most important predictors 
of the outcome were the values of SAPS II and the CRP values for day 2 (CRP 2), mutually 
combined. This model shows the predictive power of 88.50% (Table 4).  
 
 B S.E. Wald sign R2 
SAPS II 0,122 0,035 12.316 0,0001*** 0,341 
CRP 2 0,008 0,003 5.083 0,024* 0,410 
Const. -6.179 1.461 17.896 0,0001 Ø 
Table 4. Multivariate logistic regression model 1 
Y=-6.179 + 0,122 × SAPS II+ 0,008 x CRP 2   
The second model includes CRP values for the second day of hospitalization, the numbers 
of positive SIRS criteria for the day 1 (SIRS.1) and the values of SAPS II score. This model 
shows the predicitve power of 80.70% (Table 5).  
 
 B S.E. Wald s R 
SIRS-1 1,9609 0,8401 5,4486 0,0196 0,2095 
SAPS II 0,1306 0,0451 8,2631 0,0040 0,2833 
CRP 2 0,0066 0,0035 3,5060 0,0611 0,1384 
Const. -11,4242 3,3775 11,4410 0,0007 Ø 
Table 5. Multivariate logistic regression model 2              
Y=-11,4242 + 1,96 × SIRS1 + 0,13 × SAPS II+ 0,007x CRP 2   
The same significance has the predicitve model that takes into account the MOF 
development and the CRP values for the second day, again in mutual combination (Table 6). 
 B S.E. Wald s R 
MOF 2,6426 0,9643 7,5103 0,0061 0,3178 
CRP 2 0,0132 0,0053 6,1129 0,0134 0,2746 
Const. -3,9805 1,3985 8,1014 0,0044 Ø 
Table 6. Multivariate logistic regression model 3 
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Y=-3,98 + 2,64 × MOF + 0,013 × CRP   
4. Discussion 
The mortality rate is  higher in the group of patients with a greater number of positive SIRS 
criteria.  SIRS duration can play an important role. In other words, persistent SIRS probably 
assumes a high risk level. [25,26,27]  The number of SIRS characteristics during the several initial 
days of hospitalization (for  days 1 and 3) and SIRS duration are significantly related to the 
outcome. In our study the number of SIRS characteristcs is a better outcome predictor, than 
the SIRS duration. Three or more positive SIRS characteristics for the first and second day in 
our series are associated with a high risk of intrahospital death. Nowadays, the 
development of resuscitation and reanimation has decreased the mortality rate. One decade 
ago, a similar approach to sepsis included an early goal – directed therapy. The properly 
timed application of enteral nutrition, prevention of nosocomial infection, decubitus, 
mechanical ventilation, or haemodialysis, have a greater significance than previously 
thought.[28,29] 
The predictive significance of physiological scoring systems is mostly expressed as «daily 
risk». We used the simple acute physiological score, second version, because of its simplicity 
of taking and calculating, and positive criticism.[22] The values of this score ranged from 17 
to 75, with the average value of 39 points. There is a highly significant difference  between  
the two groups related to the outcome. The overall predicting accuracy of intrahospital 
mortality in our series is very good (near 80%), greater than the ISS. SAPS II, using the 
method of multivariate logistic regression, entered as one of the most important variables 
into the model of regression for the outcome prediction. We feel that this data shows the 
usefulness of the physiological scoring systems application in the assessment of the patient's 
response to trauma and in outcome predicting. The best accuracy is obtained when 
combining physiological and anatomical scores, with the determination of specific 
inflammation markers, which is the recommendation of many researchers.[30,31] 
The peak of IL-6 serum levels  is related to surgical trauma, with the surgical procedure 
duration and blood loss.[43] Stratification of injured patients according to injury severity and 
the outcome, takes into account the cytokine status. [11,33] According to cytokine serum levels, 
patients are divided into four groups, with prognostic significance. The number of patients 
with the worst prognostic group, the third (over 250 pg/L) and the fourth (over 500 pg/L) in 
our series is very high (over 45%); there is  a highly significant difference among the patients 
related to the outcome (p=0.0000). In deceased patients high levels persists in the form of 
plateau and decrease minimally (in case of death). Significantly high values for the first and 
second day are found, but the majority  indicate that the window is closed after three days, 
meaning that values after that period have  no predictive power. 
Clinical IL-10 application was disappointing and  its  administration immediately after the 
trauma or surgical intervention didn’t improve the survival rate. Also, this cytokine failed to 
decrease the level of other proinflammatory cytokines (TNF, IL-1, IL-8) in serum and fail in 
 Sepsis – An Ongoing and Significant Challenge 166 
blocking the neutrophil accumulation in the lungs.[36]  The IL-10 administration increase mice 
mortality during endotoxaemia, while blocking IL-10 activity decreased mortality in the 
Klebsiella and Candida infected mice.[34] In patients with an inevitable negative outcome 
(extensive combustions, critically injured patients), IL-10 serum levels are the highest.  On the 
other hand, in patients with clinical signs of ARDS, the low IL-10 levels in the bronchalveolar 
lavage are associated with the increased mortality.  These results  pose a question when it 
would be the problem to have too little or too much IL-10; in other words, when IL-10 can be 
taken as a relevant marker or a mediator. The ratio of IL-6 to IL-10 may be a predictive factor 
in SIRS.[33]  In our study we partially confirmed the disappointing overwhelming reports on a 
possible protective role of IL-10 in human sepsis.[34]  The kinetics of its concentration is very 
similar to the IL-6 kinetics and appears to be more realistic in describing the illness severity 
and the outcome, than in playing a protective role in critically injured patients. Based upon our 
results, IL-10 kinetics and its high serum levels in the groups with the poorer outcome are not 
in favor of its protective role as a cytokine, but it can be used as a good predictor of injury 
course and the outcome for some group of patients.[14, 37,38] 
A signifficant correlation between non-pancreatic PLA2 levels and the development of 
respiratory insufficiency and hypotension in sepsis was found.[39]  There is an obvious 
increase in non-pancreatic PLA2 levels in relation to mortality. There are several 
contradictory results on the correlation of this enzyme plasma concentration with some 
diseases, their course and the outcome. It was found in patients with multiple trauma that 
PLA2 group II might be considered as an important predictor of injury severity  the 
outcome, and it was shown in several studies that  its concentrations and kinetics are well 
correlated to the course and the outcome of septic syndrome.[40]  On the other hand, the role 
of PLA2 II in different conditions (multiple injuries, acute pancreatitis, sepsis) was studied 
and it was shown that in case of critical injuries (ISS average value was 41) the PLA2 levels 
correlate well to the illness severity and the outcome.[41,42] In our series, average PLA2 II 
values for each day have been compared to the septic syndrome and multiorganic 
insufficiency development and the outcome. The highest signifficance exists in average 
serum concentrations on the second and third day, related to the outcome. On the seventh 
day there is a peak value in patients with a negative outcome, while serum levels on the 10th 
and 14th day decreased.  We created three models concerning the outcome. Al the models 
included CRP values for the second day of hospitalization.  In the first model SAPS II values 
were added. Because of the availability of the needed data and the fact that it can be 
calculated on the second day of the hospitalization, this is the model we would like to 
emphasize. The second model includes the number of SIRS characteristics on the first day, 
SAPS II values and CRP values on second day of hospitalization. The third model that 
points out the probability of intrahospital death, except the CRP value for the second day, 
takes into account the presence of MOF (MOF present – 1; MOF absent – 0). Although the 
accuracy of this model is very high, the calculating of MOF score can be very complicated, 
and the MOF presence itself is a serious prognostic sign that decreases the predictive power 
of this model. We think that the utilization of  these models in our practice would be very 
interesting and would test its value in the best way. 
 
Early Detection of Sepsis, MOF and Outcome Prediction in Severely Traumatized Patients 167 
5. Conclusion 
In our study the number of positive SIRS characteristics is related to the outcome. SAPS II 
values are significantly different in the survived and deceased groups. ISS enables very 
good quantification of the patients' injuries and represents a precise outcome predictor. It is 
possible to predict the outcome based on CRP kinetics from Day 1 to Day 10. IL-6 kinetics in 
the first seven days, before the clear appearance of clinical symptoms, can point to the 
possible outcome. A high average IL-10 serum level in the initial 24 hours after the injury, 
the second and the third day announce a negative course and injury outcome. PLA2 in our 
series reflects the injury severity and systemic response, and its average daily concentrations 
with high probability can divide patients into groups of the survived and the deceased. It is 
possible to create predictive models based on our results considering the outcome. The most 
important parameters are SAPS II values and CRP values on  day 2 combined. 
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